The University of Southampton
University of Southampton Institutional Repository

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Growing evidence points to the potential of agonistic anti-CD40 mAb as adjuvants for vaccination against cancer. These appear to act by maturing DC and allowing them to prime CD8 cytotoxic T lymphocytes (CTL). While it is well established that optimal T-cell priming requires co-stimulation via B7:CD28, recent studies emphasize the contribution of TNF receptors to this process. To understand how anti-CD40 mAb triggers effective anti-tumor immunity we investigated the role of TNFR superfamily members CD27 and 4-1BB in the generation of this immunity and showed that, while partially dependent on 4-1BB:4-1BBL engagement, it is completely reliant on CD27:CD70 interactions. Importantly, blocking CD70, and to some extent 4-1BBL, during anti-CD40 treatment, prevented accumulation of tumor reactive T cells and subsequent tumor protection. However, it did not influence changes in DC number, phenotype, nor the activity of CTL once immunity was established. We conclude that CD27:CD70 and 4-1BB:4-1BBL interactions are needed for DC-driven accumulation of anti-tumor CTL following anti-CD40 mAb treatment. Finally, in support of the critical role for CD70:CD27, we show for the first time that agonistic anti-CD27 mAb given without a DC maturation signal completely protect tumor-bearing mice and provides a highly potent reagent for boosting anti-tumor T cell immunity.
0006-4971
4810-4815
French, Ruth R.
a95ea7a1-7aeb-4c20-998e-fde663613fd1
Taraban, Vadim Y.
d709dcbb-ff36-4514-85da-08ca68aafcd3
Crowther, Graham R.
0ef62e5c-2b5d-4c31-a3a5-8e74c23e024b
Rowley, Tania F.
3a29866f-3e2c-4ee8-8fe6-fd189ac1eb3d
Gray, Juliet C.
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
Johnson, Peter W.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Tutt, Alison L.
46ce577b-aea1-412d-84ea-fc4dab794469
Al-Shamkhani, Aymen
0a40b3ce-9d71-4d41-9369-7212f0a84504
Glennie, Martin J.
9f6f0eff-4560-48c2-80cd-0ec116110ded
French, Ruth R.
a95ea7a1-7aeb-4c20-998e-fde663613fd1
Taraban, Vadim Y.
d709dcbb-ff36-4514-85da-08ca68aafcd3
Crowther, Graham R.
0ef62e5c-2b5d-4c31-a3a5-8e74c23e024b
Rowley, Tania F.
3a29866f-3e2c-4ee8-8fe6-fd189ac1eb3d
Gray, Juliet C.
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
Johnson, Peter W.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Tutt, Alison L.
46ce577b-aea1-412d-84ea-fc4dab794469
Al-Shamkhani, Aymen
0a40b3ce-9d71-4d41-9369-7212f0a84504
Glennie, Martin J.
9f6f0eff-4560-48c2-80cd-0ec116110ded

French, Ruth R., Taraban, Vadim Y., Crowther, Graham R., Rowley, Tania F., Gray, Juliet C., Johnson, Peter W., Tutt, Alison L., Al-Shamkhani, Aymen and Glennie, Martin J. (2007) Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation. Blood, 109 (11), 4810-4815. (doi:10.1182/blood-2006-11-057216).

Record type: Article

Abstract

Growing evidence points to the potential of agonistic anti-CD40 mAb as adjuvants for vaccination against cancer. These appear to act by maturing DC and allowing them to prime CD8 cytotoxic T lymphocytes (CTL). While it is well established that optimal T-cell priming requires co-stimulation via B7:CD28, recent studies emphasize the contribution of TNF receptors to this process. To understand how anti-CD40 mAb triggers effective anti-tumor immunity we investigated the role of TNFR superfamily members CD27 and 4-1BB in the generation of this immunity and showed that, while partially dependent on 4-1BB:4-1BBL engagement, it is completely reliant on CD27:CD70 interactions. Importantly, blocking CD70, and to some extent 4-1BBL, during anti-CD40 treatment, prevented accumulation of tumor reactive T cells and subsequent tumor protection. However, it did not influence changes in DC number, phenotype, nor the activity of CTL once immunity was established. We conclude that CD27:CD70 and 4-1BB:4-1BBL interactions are needed for DC-driven accumulation of anti-tumor CTL following anti-CD40 mAb treatment. Finally, in support of the critical role for CD70:CD27, we show for the first time that agonistic anti-CD27 mAb given without a DC maturation signal completely protect tumor-bearing mice and provides a highly potent reagent for boosting anti-tumor T cell immunity.

This record has no associated files available for download.

More information

Published date: 2007

Identifiers

Local EPrints ID: 44623
URI: http://eprints.soton.ac.uk/id/eprint/44623
ISSN: 0006-4971
PURE UUID: b6b75284-25d1-466f-8886-fb7a91a3e225
ORCID for Juliet C. Gray: ORCID iD orcid.org/0000-0002-5652-4722
ORCID for Peter W. Johnson: ORCID iD orcid.org/0000-0003-2306-4974
ORCID for Aymen Al-Shamkhani: ORCID iD orcid.org/0000-0003-0727-4189

Catalogue record

Date deposited: 01 Mar 2007
Last modified: 16 Mar 2024 03:33

Export record

Altmetrics

Contributors

Author: Ruth R. French
Author: Vadim Y. Taraban
Author: Graham R. Crowther
Author: Tania F. Rowley
Author: Juliet C. Gray ORCID iD
Author: Alison L. Tutt

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×